Clinical Trial Update: To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating FE 999315 in Japanese patients with mild to moderate active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• FE 999315

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Colitis, Ulcerative | Phase 3 | Status: COMPLETED